Philip Lienau Selected Research

Philip Lienau Research Topics

Disease

18	Neoplasms (Cancer) 03/2024 - 04/2009
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 11/2022
2	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 01/2020
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 04/2009
1	Osteitis 01/2023
1	Aneuploidy (Aneuploid) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Genomic Instability 01/2020
1	Carcinogenesis 01/2017
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2017
1	Breast Neoplasms (Breast Cancer) 04/2009
1	Brain Neoplasms (Brain Tumor) 04/2009
1	Neoplasm Metastasis (Metastasis) 04/2009
1	Glioblastoma (Glioblastoma Multiforme) 04/2009
1	Melanoma (Melanoma, Malignant) 04/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2012
4	Phosphotransferases (Kinase)IBA 06/2021 - 01/2017
2	LigandsIBA 01/2023 - 11/2022
2	Phenobarbital (Luminal)FDA Link 01/2023 - 11/2022
2	Positive Transcriptional Elongation Factor BIBA 12/2021 - 01/2017
2	BAY 1895344IBA 01/2020 - 01/2020
2	atuveciclibIBA 11/2017 - 01/2017
2	roniciclibIBA 01/2016 - 07/2013
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016 - 10/2012
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 03/2024
1	PPAR gammaIBA 01/2023
1	SR10221IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	LipidsIBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 06/2021
1	ChromatinIBA 06/2021
1	Adenosine Monophosphate (AMP)IBA 06/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2021
1	Lipase (Acid Lipase)FDA Link 06/2021
1	AndrogensIBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Thorium-227IBA 01/2021
1	BAY 2315497IBA 01/2021
1	Androgen Receptor AntagonistsIBA 01/2020
1	olaparibIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	darolutamideIBA 01/2020
1	quinolineIBA 01/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2019
1	6- (4- (diethylamino)- 3- nitrophenyl)- 5- methyl- 4,5- dihydropyridazin- 3(2H)- oneIBA 11/2019
1	BAY 1143269IBA 01/2017
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2017
1	Eukaryotic Initiation Factor-4EIBA 01/2017
1	Cyclin-Dependent Kinase 9IBA 01/2017
1	NocodazoleIBA 01/2016
1	Antimitotic AgentsIBA 01/2016
1	Retinoblastoma ProteinIBA 01/2016
1	Epothilones (Epothilone)IBA 04/2009
1	Temozolomide (Temodar)FDA LinkGeneric 04/2009
1	sagopiloneIBA 04/2009
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2009

Therapy/Procedure

7	Therapeutics 11/2022 - 01/2016
1	Drug Therapy (Chemotherapy) 10/2012